Skip to main content

Advertisement

Log in

Long-term remission from gout associated with fenofibrate therapy

  • CASE REPORT
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

 Short-term studies with fenofibrate, an established treatment for hyperlipidaemia, have shown that its unique side effect of urate lowering is mediated through enhanced renal urate clearance. The long-term effects of fenofibrate on hyperuricaemia and gout have not previously been reported. We report two patients with hyperlipidaemia in association with hyperuricaemia in whom long-term fenofibrate therapy was associated with a sustained reduction in serum urate and lipid levels, together with remission from recurrent attacks of acute gout. The mechanisms involved in these effects and the potential role for fenofibrate in the management of gout are discussed.

Keywords

 Fenofibrate · Gout · Treatment

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 11 March 2002 / Accepted: 18 July 2002

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hepburn, A., Kaye, S. & Feher, M. Long-term remission from gout associated with fenofibrate therapy. Clin Rheumatol 22, 73–76 (2003). https://doi.org/10.1007/s10067-002-0658-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-002-0658-1

Keywords

Navigation